Vertebral Compression Fracture Devices Market by Product (Balloon Kyphoplasty Devices and Vertebroplasty Devices) and Surgery (Open Spine Surgery and Minimally Invasive Spine Surgery) - Global Opportunity Analysis and Industry Forecast, 2014-2022
Vertebral compression fracture (VCF) is a type of spinal disorder caused by the fracture of bones in the spinal cord due to osteoporosis, arthritis, and trauma. The surgical approach for the treatment of VCF includes vertebroplasty and balloon kyphoplasty. These procedures involve injecting cement in the fractured vertebral body to achieve immediate pain relief and stability.
The global VCF devices market generated $748 million in 2015, and is projected to reach $1,109 million by 2022, registering a CAGR of 5.7% from 2016 to 2022. The market is driven by factors such as increase in geriatric population, rise in incidence of osteoporosis & arthritis, and growth in patient awareness about advancements in spinal surgeries, such as artificial disc replacement. However, risk associated with post-surgical complications, i.e., hemorrhage and vertebral posterior element fracture, and stringent regulatory approval procedures are expected to hamper the market growth.
The global VCF devices market is segmented on the basis on product type, surgery, and region. Based on the type of product, the market is segmented into balloon kyphoplasty and vertebroplasty. Based on the type of surgery, the market is bifurcated into open spine surgery and minimally invasive spine surgery. The market is analyzed based on four regions, namely North America, Europe, Asia-Pacific, and LAMEA.
The key players have adopted product development strategies, including product launches, approvals, and clinical trials over the past few years. For instance, in 2014, Benvenue Medical commercially launched Kiva VCF treatment featuring a proprietary, cylindrical implant obtained from a medical polymer that provides a predictable structural support for the vertebral body, and a reservoir to contain and direct the flow of bone cement.
KEY BENEFITS FOR STAKEHOLDERS
By Product
The global VCF devices market generated $748 million in 2015, and is projected to reach $1,109 million by 2022, registering a CAGR of 5.7% from 2016 to 2022. The market is driven by factors such as increase in geriatric population, rise in incidence of osteoporosis & arthritis, and growth in patient awareness about advancements in spinal surgeries, such as artificial disc replacement. However, risk associated with post-surgical complications, i.e., hemorrhage and vertebral posterior element fracture, and stringent regulatory approval procedures are expected to hamper the market growth.
The global VCF devices market is segmented on the basis on product type, surgery, and region. Based on the type of product, the market is segmented into balloon kyphoplasty and vertebroplasty. Based on the type of surgery, the market is bifurcated into open spine surgery and minimally invasive spine surgery. The market is analyzed based on four regions, namely North America, Europe, Asia-Pacific, and LAMEA.
The key players have adopted product development strategies, including product launches, approvals, and clinical trials over the past few years. For instance, in 2014, Benvenue Medical commercially launched Kiva VCF treatment featuring a proprietary, cylindrical implant obtained from a medical polymer that provides a predictable structural support for the vertebral body, and a reservoir to contain and direct the flow of bone cement.
KEY BENEFITS FOR STAKEHOLDERS
- This report offers an extensive analysis of the current trends and emerging estimations of the global VCF devices market for the period of 2014–2022 to identify the prevailing opportunities
- Comprehensive analysis of all geographical regions is provided along with the factors that drive and restrict the market growth.
- Quantitative analysis of the market segments is provided for the period of 2014-2022 to showcase the financial scenario.
- The regional and country-level analyses of the market are provided in the report.
By Product
- Balloon Kyphoplasty Devices
- Vertebroplasty Devices
- Open Spine Surgery
- Minimally Invasive Spine Surgery
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- Germany
- UK
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Alphatec Holdings, Inc.
- Benvenue Medical
- Depuy Synthes (Johnson & Johnson)
- Globus Medical, Inc.
- Medtronic plc
- Orthovita, Inc.
- Osseon LLC
- Stryker Corporation
- VEXIM SA
- Zimmer Biomet Holdings, Inc.
- Algea Therapies
- Spine Wave, Inc.
- Spirit Spine
- Stцckli Medical AG
CHAPTER 1 INTRODUCTION
1.1. KEY BENEFITS
1.2. KEY MARKET SEGMENTS
1.3. KEY PLAYERS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top winning strategies
3.2.1.1. Competitive intelligence and strategies of companies
3.2.2. Top investment pockets
3.3. MARKET SHARE ANALYSIS, 2015
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.1.1. Growing elderly population
3.4.1.2. Increasing incidences of arthritis and osteoporosis
3.4.1.3. Technological advancements in the VCF devices
3.4.1.4. Shift towards minimal invasive VCF procedures
3.4.2. Restraints
3.4.2.1. Stringent regulatory approval procedure
3.4.3. Opportunities
3.4.3.1. Emerging markets to drive the demand for VCF devices
3.4.3.2. Popularization of percutaneous vertebral augmentation (PVA) treatment
3.4.4. Impact analysis
3.5. PORTERS FIVE FORCES ANALYSIS
3.5.1. Bargaining power of buyers
3.5.2. Bargaining power of suppliers
3.5.3. Threat of substitutes
3.5.4. Threat of new entrants
3.5.5. Competitive rivalry
3.6. GOVERNMENT REGULATIONS
CHAPTER 4 GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Key market trends
4.1.2. Growth factors and opportunities
4.1.3. Market size and forecast
4.1.4. Global VCF Device Implantations, By Type
4.1.5. Balloon kyphoplasty devices
4.1.5.1. Market size and forecast
4.1.6. Vertebroplasty devices
4.1.6.1. Market size and forecast
CHAPTER 5 GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. OPEN SURGERY
5.2.1. Market size and forecast
5.3. MINIMALLY INVASIVE SURGERY
5.3.1. Market size and forecast
CHAPTER 6 GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY REGION
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Growth factors and opportunities
6.2.3. Market size and forecast
6.2.4. U.S. market size and forecast
6.2.5. Canada market size and forecast
6.2.6. Mexico market size and forecast
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Growth factors and opportunities
6.3.3. Market size and forecast
6.3.4. France market size and forecast
6.3.5. Germany market size and forecast
6.3.6. UK market size and forecast
6.3.7. Spain market size and forecast
6.3.8. Italy market size and forecast
6.3.9. Rest of Europe market size and forecast
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Growth factors and opportunities
6.4.3. Market size and forecast
6.4.4. India market size and forecast
6.4.5. China market size and forecast
6.4.6. Japan market size and forecast
6.4.7. South Korea market size and forecast
6.4.8. Australia market size and forecast
6.4.9. Rest of Asia-Pacific market size and forecast
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Growth factors and opportunities
6.5.3. Market size and forecast
6.5.4. Brazil market size and forecast
6.5.5. Saudi Arabia market size and forecast
6.5.6. South Africa market size and forecast
6.5.7. Rest of LAMEA market size and forecast
CHAPTER 7 COMPANY PROFILES
7.1. ALPHATEC HOLDINGS, INC.
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating product categories
7.1.4. Business Performance
7.1.5. Key strategic moves and developments
7.2. OSSEON LLC
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Key strategic moves and developments
7.3. ORTHOVITA, INC.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Key strategic moves and developments
7.4. JOHNSON & JOHNSON
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Business performance
7.4.5. Key strategic moves and developments
7.5. GLOBUS MEDICAL, INC.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating product categories
7.5.4. Business performance
7.5.5. Key strategic moves and developments
7.5.6. Key strategy share
7.6. MEDTRONIC PLC
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Business performance
7.6.5. Key strategic moves and developments
7.6.6. Key strategy share
7.7. BENVENUE MEDICAL
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Key strategic moves and developments
7.7.4. Key strategy share
7.8. VEXIM SA
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Key strategic moves and developments
7.8.4. Key strategy share
7.9. STRYKER CORPORATION
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Business performance
7.9.5. Key strategic moves and developments
7.10. ZIMMER BIOMET HOLDINGS, INC.
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating product categories
7.10.4. Business performance
7.10.5. Key strategic moves and developments
7.10.6. Key strategy share
1.1. KEY BENEFITS
1.2. KEY MARKET SEGMENTS
1.3. KEY PLAYERS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top winning strategies
3.2.1.1. Competitive intelligence and strategies of companies
3.2.2. Top investment pockets
3.3. MARKET SHARE ANALYSIS, 2015
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.1.1. Growing elderly population
3.4.1.2. Increasing incidences of arthritis and osteoporosis
3.4.1.3. Technological advancements in the VCF devices
3.4.1.4. Shift towards minimal invasive VCF procedures
3.4.2. Restraints
3.4.2.1. Stringent regulatory approval procedure
3.4.3. Opportunities
3.4.3.1. Emerging markets to drive the demand for VCF devices
3.4.3.2. Popularization of percutaneous vertebral augmentation (PVA) treatment
3.4.4. Impact analysis
3.5. PORTERS FIVE FORCES ANALYSIS
3.5.1. Bargaining power of buyers
3.5.2. Bargaining power of suppliers
3.5.3. Threat of substitutes
3.5.4. Threat of new entrants
3.5.5. Competitive rivalry
3.6. GOVERNMENT REGULATIONS
CHAPTER 4 GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Key market trends
4.1.2. Growth factors and opportunities
4.1.3. Market size and forecast
4.1.4. Global VCF Device Implantations, By Type
4.1.5. Balloon kyphoplasty devices
4.1.5.1. Market size and forecast
4.1.6. Vertebroplasty devices
4.1.6.1. Market size and forecast
CHAPTER 5 GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. OPEN SURGERY
5.2.1. Market size and forecast
5.3. MINIMALLY INVASIVE SURGERY
5.3.1. Market size and forecast
CHAPTER 6 GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY REGION
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Growth factors and opportunities
6.2.3. Market size and forecast
6.2.4. U.S. market size and forecast
6.2.5. Canada market size and forecast
6.2.6. Mexico market size and forecast
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Growth factors and opportunities
6.3.3. Market size and forecast
6.3.4. France market size and forecast
6.3.5. Germany market size and forecast
6.3.6. UK market size and forecast
6.3.7. Spain market size and forecast
6.3.8. Italy market size and forecast
6.3.9. Rest of Europe market size and forecast
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Growth factors and opportunities
6.4.3. Market size and forecast
6.4.4. India market size and forecast
6.4.5. China market size and forecast
6.4.6. Japan market size and forecast
6.4.7. South Korea market size and forecast
6.4.8. Australia market size and forecast
6.4.9. Rest of Asia-Pacific market size and forecast
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Growth factors and opportunities
6.5.3. Market size and forecast
6.5.4. Brazil market size and forecast
6.5.5. Saudi Arabia market size and forecast
6.5.6. South Africa market size and forecast
6.5.7. Rest of LAMEA market size and forecast
CHAPTER 7 COMPANY PROFILES
7.1. ALPHATEC HOLDINGS, INC.
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating product categories
7.1.4. Business Performance
7.1.5. Key strategic moves and developments
7.2. OSSEON LLC
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Key strategic moves and developments
7.3. ORTHOVITA, INC.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Key strategic moves and developments
7.4. JOHNSON & JOHNSON
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Business performance
7.4.5. Key strategic moves and developments
7.5. GLOBUS MEDICAL, INC.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating product categories
7.5.4. Business performance
7.5.5. Key strategic moves and developments
7.5.6. Key strategy share
7.6. MEDTRONIC PLC
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Business performance
7.6.5. Key strategic moves and developments
7.6.6. Key strategy share
7.7. BENVENUE MEDICAL
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Key strategic moves and developments
7.7.4. Key strategy share
7.8. VEXIM SA
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Key strategic moves and developments
7.8.4. Key strategy share
7.9. STRYKER CORPORATION
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Business performance
7.9.5. Key strategic moves and developments
7.10. ZIMMER BIOMET HOLDINGS, INC.
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating product categories
7.10.4. Business performance
7.10.5. Key strategic moves and developments
7.10.6. Key strategy share
LIST OF TABLES
TABLE 1. GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 2. GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICE IMPLANTATIONS, BY TYPE (THOUSAND UNITS), 2014-2022
TABLE 3. GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY TYPE ($MILLION), 2014-2022
TABLE 4. GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET FOR OPEN SURGERY, BY REGION ($MILLION), 2014-2022
TABLE 5. GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET FOR MINIMALLY INVASIVE SURGERY, BY REGION ($MILLION), 2014-2022
TABLE 6. GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 7. NORTH AMERICA VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 8. EUROPE VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 9. ASIA-PACIFIC VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 10. LAMEA VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 11. ALPHATEC: COMPANY SNAPSHOT
TABLE 12. ALPHATEC: PRODUCT CATEGORIES
TABLE 13. OSSEON: COMPANY SNAPSHOT
TABLE 14. ORTHOVITA: COMPANY SNAPSHOT
TABLE 15. J&J: COMPANY SNAPSHOT
TABLE 16. J&J: BUSINESS SEGMENTS
TABLE 17. GLOBUS MEDICAL: COMPANY SNAPSHOT
TABLE 18. GLOBUS MEDICAL: PRODUCT CATEGORIES
TABLE 19. MEDTRONIC: COMPANY SNAPSHOT
TABLE 20. MEDTRONIC: BUSINESS SEGMENTS
TABLE 21. BENVENUE: COMPANY SNAPSHOT
TABLE 22. VEXIM: COMPANY SNAPSHOT
TABLE 23. STRYKER: COMPANY SNAPSHOT
TABLE 24. STRYKER: BUSINESS SEGMENTS
TABLE 25. ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 26. ZIMMER BIOMET: BUSINESS SEGMENTS
TABLE 1. GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 2. GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICE IMPLANTATIONS, BY TYPE (THOUSAND UNITS), 2014-2022
TABLE 3. GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY SURGERY TYPE ($MILLION), 2014-2022
TABLE 4. GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET FOR OPEN SURGERY, BY REGION ($MILLION), 2014-2022
TABLE 5. GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET FOR MINIMALLY INVASIVE SURGERY, BY REGION ($MILLION), 2014-2022
TABLE 6. GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 7. NORTH AMERICA VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 8. EUROPE VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 9. ASIA-PACIFIC VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 10. LAMEA VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 11. ALPHATEC: COMPANY SNAPSHOT
TABLE 12. ALPHATEC: PRODUCT CATEGORIES
TABLE 13. OSSEON: COMPANY SNAPSHOT
TABLE 14. ORTHOVITA: COMPANY SNAPSHOT
TABLE 15. J&J: COMPANY SNAPSHOT
TABLE 16. J&J: BUSINESS SEGMENTS
TABLE 17. GLOBUS MEDICAL: COMPANY SNAPSHOT
TABLE 18. GLOBUS MEDICAL: PRODUCT CATEGORIES
TABLE 19. MEDTRONIC: COMPANY SNAPSHOT
TABLE 20. MEDTRONIC: BUSINESS SEGMENTS
TABLE 21. BENVENUE: COMPANY SNAPSHOT
TABLE 22. VEXIM: COMPANY SNAPSHOT
TABLE 23. STRYKER: COMPANY SNAPSHOT
TABLE 24. STRYKER: BUSINESS SEGMENTS
TABLE 25. ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 26. ZIMMER BIOMET: BUSINESS SEGMENTS
LIST OF FIGURES
FIGURE 1. GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY TYPE ($MILLION), 2015 VS 2022
FIGURE 2. VERTEBRAL COMPRESSION FRACTURE MARKET SEGMENTATION
FIGURE 3. TOP WINNING STRATEGIES
FIGURE 4. TOP WINNING STRATEGIES, ORGANIC AND INORGANIC
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. DEVELOPMENT STRATEGIES ADOPTED BY COMPANIES
FIGURE 7. TOP INVESTMENT POCKETS
FIGURE 8. MARKET SHARE ANALYSIS, 2015
FIGURE 9. BARGAINING POWER OF BUYERS
FIGURE 10. BARGAINING POWER OF SUPPLIERS
FIGURE 11. THREAT OF SUBSTITUTES
FIGURE 12. THREAT OF NEW ENTRANTS
FIGURE 13. COMPETITIVE RIVALRY
FIGURE 14. VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET FOR BALLOON KYPHOPLASTY DEVICES ($MILLION), 20142022
FIGURE 15. VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET FOR VERTEBROPLASTY DEVICES ($MILLION), 20142022
FIGURE 16. U.S.: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 17. CANADA: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 18. MEXICO: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 19. POPULATION STRUCTURE BY MAJOR AGE GROUPS, EU-28
FIGURE 20. FRANCE: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 21. GERMANY: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 22. UK: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 23. SPAIN: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 24. ITALY: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 25. REST OF EUROPE: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 26. INDIA: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 27. CHINA: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 28. JAPAN: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 29. SOUTH KOREA: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 30. AUSTRALIA: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 31. REST OF ASIA-PACIFIC: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 32. BRAZIL: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 33. SAUDI ARABIA: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 34. SOUTH AFRICA: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 35. REST OF LAMEA: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 1. GLOBAL VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET, BY TYPE ($MILLION), 2015 VS 2022
FIGURE 2. VERTEBRAL COMPRESSION FRACTURE MARKET SEGMENTATION
FIGURE 3. TOP WINNING STRATEGIES
FIGURE 4. TOP WINNING STRATEGIES, ORGANIC AND INORGANIC
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. DEVELOPMENT STRATEGIES ADOPTED BY COMPANIES
FIGURE 7. TOP INVESTMENT POCKETS
FIGURE 8. MARKET SHARE ANALYSIS, 2015
FIGURE 9. BARGAINING POWER OF BUYERS
FIGURE 10. BARGAINING POWER OF SUPPLIERS
FIGURE 11. THREAT OF SUBSTITUTES
FIGURE 12. THREAT OF NEW ENTRANTS
FIGURE 13. COMPETITIVE RIVALRY
FIGURE 14. VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET FOR BALLOON KYPHOPLASTY DEVICES ($MILLION), 20142022
FIGURE 15. VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET FOR VERTEBROPLASTY DEVICES ($MILLION), 20142022
FIGURE 16. U.S.: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 17. CANADA: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 18. MEXICO: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 19. POPULATION STRUCTURE BY MAJOR AGE GROUPS, EU-28
FIGURE 20. FRANCE: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 21. GERMANY: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 22. UK: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 23. SPAIN: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 24. ITALY: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 25. REST OF EUROPE: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 26. INDIA: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 27. CHINA: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 28. JAPAN: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 29. SOUTH KOREA: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 30. AUSTRALIA: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 31. REST OF ASIA-PACIFIC: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 32. BRAZIL: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 33. SAUDI ARABIA: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 34. SOUTH AFRICA: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
FIGURE 35. REST OF LAMEA: VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET ($MILLION), 2014-2022
